EC approves  subcutaneous route of administration in Sandoz biosimilar, Binocrit

EC approves subcutaneous route of administration in Sandoz biosimilar, Binocrit

novartis_logo
Sandoz, a Novartis division and the global leader in biosimilars, announced today that the European Commission (EC) has approved a type II variation for the addition of a subcutaneous (s.c.) route of administration in its drug Binocrit (epoetin alfa), a prescription medicine that stimulates the bone marrow to produce red blood cells (anemia in either the nephrology or oncology setting).
“By expanding our biosimilar offering to the healthcare community, the EC approval of a subcutaneous route of administration for use in our Binocrit’s nephrology indication will mean more choice for healthcare professionals as well as increased convenience for patients” said Carol Lynch, Global Head Biopharmaceuticals, Sandoz.
The EU approval was based on data from the SENSE clinical study – an open label, single arm, multicenter study to evaluate the safety and immunogenicity of HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in pre-dialysis and dialysis patients.
The company says it is committed to increasing patient access to high-quality, life-enhancing biosimilars

You might also like

Worldwide switch to bivalent oral polio vaccine begins on Sunday

The trivalent oral polio vaccine has been instrumental in the near-eradication of the disease worldwide, but the vaccine still has some challenges that can be addressed by switching to a

PHARMA NEWS 0 Comments

Firm offers free hypertension screening for Abuja residents

A Nigerian pharmaceutical company, Neimeth international pharmaceuticals plc, plans to conduct free hypertension screening for residents of the Federal Capital Territory, Abuja. The exercise will also include distribution of free

NEWS 0 Comments

Fidson Pharma rewards Astymin users

… Rolls out cash promo Users of Astymin brand of multivitamin, will now gain financial and nutritional reward through constant use of the multivitamin. Makers of the brand, Fidson Pharmaceuticals

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply